Canada
Study aims to prove safety of psilocybe mushrooms so Canadian regulators can expand access to psychedelic therapy
Hi, what are you looking for?
Mugglehead Investment Magazine
All posts tagged "psychedelic research"
Industry update
Thursday, April 27, four experts including MAPS founder Rick Doblin and former US drug policy advisor Kevin Sabet debate the merits of psychedelic reform
Medical and Pharmaceutical
The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine
Industry update
Australia is funding research to see if magic mushrooms and ecstasy can treat depression and PTSD
Industry update
The Washington State-based biotech startup's application covers a range of cannabinoids and psilocybin compounds
Psychedelics
A first-of-its-kind clinical trial shows a dramatic drop in depression in over half of patients who received a synthetic version of the compound
Cannabis
Many of the firm's well-known faces took lumps in the weed sector, mistakes they say set them up for success in psychedelics
The weed wire
The new hub will focus on the rapidly advancing field by adding unique public education and spiritual components
The weed wire
With deep Canadian and U.S. military ties, NeuroPharm Inc. is about to launch psychedelic-based clinical trials
The weed wire
CaaMTech will be researching synthetic tryptamine-based compounds as part of a cooperative R&D program
